StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.
T2 Biosystems Trading Down 5.0 %
Shares of T2 Biosystems stock opened at $0.26 on Tuesday. The firm’s 50-day moving average is $0.27 and its 200 day moving average is $0.29. T2 Biosystems has a 1 year low of $0.05 and a 1 year high of $6.24.
T2 Biosystems (NASDAQ:TTOO – Get Free Report) last posted its earnings results on Monday, August 7th. The medical equipment provider reported ($0.08) earnings per share (EPS) for the quarter. The business had revenue of $1.96 million for the quarter.
Institutional Investors Weigh In On T2 Biosystems
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
- Five stocks we like better than T2 Biosystems
- Best Stocks Under $10.00
- WeWork Stock Soars: Meme Stock Madness or Mirage?
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Low-Cost ETFs That Are Crushing SPY
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Shutterstock is the Value Stock they don’t want you to know about
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.